Cambridge, MA | May 2023
Shekar Shetty, CEO and Dr. Piercen Oliver, VP R&D of Clear Scientific presented at the Charles River Sixth Annual World Congress, a global event. The conference is an ongoing effort to progress and raise awareness to how advanced modalities are disrupting drug development. This event showcased how advanced modalities are shaping drug development through presentations from biopharmaceutical companies, academia, panel discussions, investors, and patient success stories.
Cambridge, MA | Nov 2023 Clear Scientific, a clinical-stage biopharmaceutical company, today announced an award from the National Institute on Drug Abuse (NIDA) of the NIH, with a total potential val
Cambridge, MA | Nov 2023 Clear Scientific, a clinical-stage biopharmaceutical company, today announced a $12M award from the National Institute on Drug Abuse of the NIH to support development of CS-1
Cambridge, MA | Oct 2023 Clear Scientific Inc., a Cambridge MA based biopharmaceutical company, announced that the FDA has approved its Investigational New Drug (IND) application for CS-1103, the fir